Redcare Pharmacy N.V. · ISIN: NL0012044747 · Directors Dealings
Insider Transaction Snapshot

Redcare Pharmacy N.V.

Directors Dealings: 21st November 2024
Reporting obligation triggered by: Eenhorst, Jasper
Trading volume: 900.415,00 EUR
Type: not specified

The Insider Transaction was made by Eenhorst, Jasper . The transaction toke place on 18th November 2024. The order was executed at the trading place XETRA. The aggregated volume was 900.415,00 EUR, based on an average price of 150,07 EUR. The nature of the Investment was not specified.

Short Selling Radar - Net Short Selling Positions

EQS-Newswire - Latest Company News, Ad-hoc News, Research

Directors Dealings

Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.

Reset filter
New DD.i/o
19 September 2024
Dr. Ing. h.c. F. Porsche Aktiengesellschaft: A reportable insider transaction was published on 18th September 2024. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 18th September 2024,

The Insider Transaction was made by Porsche, Dr. Wolfgang . The transaction toke place on 10th September 2024. The order was executed at the trading place Frankfurt. . The aggregated volume was 19.494,00 EUR, based on an average price of 64,98 EUR. The nature of the Investment was Buy.

Dr. Ing. h.c. F. Porsche Aktiengesellschaft
08 August 2024
Dr. Ing. h.c. F. Porsche Aktiengesellschaft: A reportable insider transaction was published on 7th August 2024. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 7th August 2024,

The Insider Transaction was made by Porsche, Dr. Wolfgang . The transaction toke place on 5th August 2024. The order was executed at the trading place Frankfurt. . The aggregated volume was 13.456,00 EUR, based on an average price of 67,28 EUR. The nature of the Investment was Buy.

Dr. Ing. h.c. F. Porsche Aktiengesellschaft
08 August 2024
Dr. Ing. h.c. F. Porsche Aktiengesellschaft: A reportable insider transaction was published on 7th August 2024. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 7th August 2024,

The Insider Transaction was made by Porsche, Dr. Wolfgang . The transaction toke place on 2nd August 2024. The order was executed at the trading place Frankfurt. . The aggregated volume was 30.104,80 EUR, based on an average price of 68,42 EUR. The nature of the Investment was Buy.

Dr. Ing. h.c. F. Porsche Aktiengesellschaft
17 June 2024
Dr. Ing. h.c. F. Porsche Aktiengesellschaft: A reportable insider transaction was published on 15th June 2024. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 15th June 2024,

The Insider Transaction was made by Porsche, Dr. Wolfgang . The transaction toke place on 13th June 2024. The order was executed at the trading place Frankfurt. . The aggregated volume was 27.920,00 EUR, based on an average price of 69,80 EUR. The nature of the Investment was Buy.

Dr. Ing. h.c. F. Porsche Aktiengesellschaft
08 December 2023
Dr. Ing. h.c. F. Porsche Aktiengesellschaft: A reportable insider transaction was published on 6th December 2023. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 6th December 2023,

The Insider Transaction was made by Porsche, Dr. Wolfgang . The transaction toke place on 28th November 2023. The order was executed at the trading place Boerse Stuttgart. . The aggregated volume was 8.296,00 EUR, based on an average price of 82,96 EUR. The nature of the Investment was Buy.

Dr. Ing. h.c. F. Porsche Aktiengesellschaft
08 December 2023
Dr. Ing. h.c. F. Porsche Aktiengesellschaft: A reportable insider transaction was published on 6th December 2023. The reporting obligation was triggered by a person related to Supervisory Board.

Transaction reporting date: 6th December 2023,

The Insider Transaction was made by Porsche, Dr. Wolfgang . The transaction toke place on 25th October 2023. The order was executed at the trading place Boerse Stuttgart. . The aggregated volume was 8.598,00 EUR, based on an average price of 85,98 EUR. The nature of the Investment was Buy.

Dr. Ing. h.c. F. Porsche Aktiengesellschaft
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

Important note:
The information presented here is usually updated once a day. Insofar as you include insider information/director dealings in your daily investment decisions and time-critical parameters play a role in the implementation of your trading strategy, you can obtain this information via a corresponding query at the BaFin or by monitoring the EQS-News intraday publications. 


Further information on the topic can be found on the following pages:

https://www.bafin.de/EN/Aufsicht/BoersenMaerkte/Transparenz/InformationspflichtenEmittenten/DirectorsDealings/directorsdealings_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2016/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/Aufsicht/BoersenMaerkte/Marktmissbrauch/Insiderueberwachung/insiderueberwachung_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2017/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/PublikationenDaten/Datenbanken/DirectorsDealings/directorsdealings_node.html